Italfarmaco
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| GIV-IN-PV NCT06093672 |
P3 | Recruiting | Polycythemia Vera | 220 | 2026-07 |
| givinostat NCT01761968 |
P2 | Active, not recruiting | Chronic Myeloproliferative Neoplasms | 90 | 2026-12 |
| ULYSSES NCT05933057 |
P3 | Recruiting | Duchenne Muscular Dystrophy | 138 | 2028-02 (+2 mo) |
| Givinostat Hydrochloride NCT06769633 |
P2 | Recruiting | Duchenne Muscular Dystrophy | 18 | 2029-12 |
| Givinostat NCT03373968 |
P2/3 | Recruiting | Duchenne Muscular Dystrophy | 206 | 2029-12 (+72 mo) |